Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist not yet approved by the MHRA or EMA
These symptoms are often linked to how GLP-1 medications affect digestion, and recognising personal triggers may help reduce discomfort and improve treatment tolerance
Apr 4, 2026 Before you add another supplement to your stack, read this
A: The GHK tripeptide has high affinity for copper(II) ions
The authors of the study concluded that the GLP-1 receptor agonist lixisenatide had a three-point beneficial effect, when compared with placebo, in the change over a 12-month period from a baseline value of approximately 15 points on a 132-point scale measuring motor disability. The active arm improved 0.04 points in the lixisenatide group and worsened 3.04 points in the placebo group
When you have an experience that makes you feel good whether its eating certain foods, socializing, drinking alcohol, or using nicotine the brains reward center is activated, causing the release of dopamine, a neurotransmitter